Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Analysis of neurosteroid levels in attention deficit hyperactivity disorder.

Strous RD, Spivak B, Yoran-Hegesh R, Maayan R, Averbuch E, Kotler M, Mester R, Weizman A.

Int J Neuropsychopharmacol. 2001 Sep;4(3):259-64.

PMID:
11602031
2.
3.

Gender differences in susceptibility to schizophrenia: Potential implication of neurosteroids.

Huang YC, Hung CF, Lin PY, Lee Y, Wu CC, Hsu ST, Chen CC, Chong MY, Lin CH, Wang LJ.

Psychoneuroendocrinology. 2017 Oct;84:87-93. doi: 10.1016/j.psyneuen.2017.06.017. Epub 2017 Jun 26.

PMID:
28686904
4.

Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.

Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J.

J Clin Endocrinol Metab. 1996 Nov;81(11):3951-60.

PMID:
8923843
5.

Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate.

Wang LJ, Hsiao CC, Huang YS, Chiang YL, Ree SC, Chen YC, Wu YW, Wu CC, Shang ZY, Chen CK.

Psychoneuroendocrinology. 2011 Sep;36(8):1209-16. doi: 10.1016/j.psyneuen.2011.02.014. Epub 2011 Mar 15.

PMID:
21411231
6.

Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia.

Strous RD, Maayan R, Lapidus R, Stryjer R, Lustig M, Kotler M, Weizman A.

Arch Gen Psychiatry. 2003 Feb;60(2):133-41.

PMID:
12578430
7.

Reduced plasma dehydroepiandrosterone sulfate levels are significantly correlated with fatigue severity in patients with primary biliary cirrhosis.

Ahboucha S, Pomier-Layrargues G, Vincent C, Hassoun Z, Tamaz R, Baker G, Butterworth RF.

Neurochem Int. 2008 Mar-Apr;52(4-5):569-74. Epub 2007 Jun 19.

PMID:
17669554
8.

Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients.

Iancu I, Tchernihovsky E, Maayan R, Poreh A, Dannon P, Kotler M, Weizman A, Strous RD.

Eur Neuropsychopharmacol. 2007 Jul;17(8):541-5. Epub 2007 Mar 8.

PMID:
17346944
9.

Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder.

Spivak B, Vered Y, Yoran-Hegesh R, Averbuch E, Mester R, Graf E, Weizman A.

Acta Psychiatr Scand. 1999 Apr;99(4):300-4.

PMID:
10223434
10.

Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology.

Strous RD, Maayan R, Lapidus R, Goredetsky L, Zeldich E, Kotler M, Weizman A.

Schizophr Res. 2004 Dec 1;71(2-3):427-34.

PMID:
15474914
11.

Salivary neurosteroid levels and behavioural profiles of children with attention-deficit/hyperactivity disorder during six months of methylphenidate treatment.

Wang LJ, Wu CC, Lee SY, Tsai YF.

J Child Adolesc Psychopharmacol. 2014 Aug;24(6):336-40. doi: 10.1089/cap.2013.0122. Epub 2014 Jun 23.

PMID:
24956271
12.

Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.

Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.

Gynecol Endocrinol. 2000 Oct;14(5):342-63.

PMID:
11109974
13.

Involvement of GABAA receptor modulating neuroactive steroids in patients with social phobia.

Laufer N, Maayan R, Hermesh H, Marom S, Gilad R, Strous R, Weizman A.

Psychiatry Res. 2005 Nov 15;137(1-2):131-6. Epub 2005 Oct 13. Erratum in: Psychiatry Res. 2006 Sep 30;144(1):95.

PMID:
16226317
14.

Lowered DHEA-S plasma levels in adult individuals with autistic disorder.

Strous RD, Golubchik P, Maayan R, Mozes T, Tuati-Werner D, Weizman A, Spivak B.

Eur Neuropsychopharmacol. 2005 May;15(3):305-9.

PMID:
15820420
15.

Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects.

Ritsner M, Maayan R, Gibel A, Weizman A.

Eur Neuropsychopharmacol. 2007 Apr;17(5):358-65. Epub 2006 Nov 21.

PMID:
17123790
16.

Thyroid hormones correlate with symptoms of hyperactivity but not inattention in attention deficit hyperactivity disorder.

Hauser P, Soler R, Brucker-Davis F, Weintraub BD.

Psychoneuroendocrinology. 1997 Feb;22(2):107-14.

PMID:
9149332
17.

The association of dehydroepiandrosterone and dehydroepiandrosterone sulfate with anxiety sensitivity and electronic diary negative affect among smokers with and without posttraumatic stress disorder.

Van Voorhees EE, Dennis MF, McClernon FJ, Calhoun PS, Buse NA, Beckham JC.

J Clin Psychopharmacol. 2013 Aug;33(4):556-60. doi: 10.1097/JCP.0b013e3182968962.

18.

Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism.

Tagawa N, Tamanaka J, Fujinami A, Kobayashi Y, Takano T, Fukata S, Kuma K, Tada H, Amino N.

Clin Chem. 2000 Apr;46(4):523-8.

19.

Neurosteroid blood levels in delinquent adolescent boys with conduct disorder.

Golubchik P, Mozes T, Maayan R, Weizman A.

Eur Neuropsychopharmacol. 2009 Jan;19(1):49-52. doi: 10.1016/j.euroneuro.2008.08.008. Epub 2008 Oct 5.

PMID:
18835698
20.

Elevated circulatory level of GABA(A)--antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder.

Spivak B, Maayan R, Kotler M, Mester R, Gil-Ad I, Shtaif B, Weizman A.

Psychol Med. 2000 Sep;30(5):1227-31.

PMID:
12027057

Supplemental Content

Support Center